Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer

To determine the therapeutic efficacy and safety of risk‐adapted stereotactic body radiation therapy (SBRT) schedules for patients with early‐stage central and ultra‐central inoperable non‐small cell lung cancer. From 2006 to 2015, 80 inoperable T1‐2N0M0 NSCLC patients were treated with two median d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Meng, Mao‐Bin, Wang, Huan‐Huan, Zaorsky, Nicholas G., Sun, Bing‐Shen, Zhu, Lei, Song, Yong‐Chun, Li, Feng‐Tong, Dong, Yang, Wang, Jing‐Sheng, Chen, Hua‐Ming, Yu, Xu‐Yao, Yuan, Zhi‐Yong
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825012/
https://ncbi.nlm.nih.gov/pubmed/31464032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14185
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars